Immunic to Participate in Industry and Investor Conferences in November
Provided By PR Newswire
Last update: Oct 29, 2025
NEW YORK, Oct. 29, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and investor conferences in November:
Read more at prnewswire.com
